AS
ASTH.US Astrana Health Inc
- Market cap
- USD 1.58B
- P/E
- 29.4x
- P/B
- 1.84x
- ROE
- 7.3%
- Dividend yield
- 0.50%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is ASTH.US undervalued?
Graham numberASTH.US trades 55.3% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Astrana Health Inc fundamental analysis
No fundamental analysis for Astrana Health Inc yet.
Astrana Health Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Astrana Health Inc
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physic…
Full company profileAstrana Health Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Astrana Health Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 57.4M | 358M | 520M | 561M | 370M | 774M | 1.14B | 1.39B | 2.03B | 3.18B | 3.95B |
| Gross Profit | 8.69M | 64.0M | 139M | 92.8M | 21.7M | 178M | 199M | 215M | 271M | 296M | 424M |
| Operating Income | -10.5M | 37.6M | 92.2M | 32.4M | 6.09M | 98.2M | 104M | 84.6M | 89.4M | 78.5M | 137M |
| EBITDA | -9.88M | 68.9M | 102M | 48.9M | 29.7M | 101M | 112M | 124M | 142M | 135M | 231M |
| Net Income | -8.97M | 25.8M | 10.8M | 14.1M | -23.8M | 68.9M | 45.2M | 60.7M | 43.1M | 22.5M | 62.8M |
| EPS | -1.49 | 0.90 | 0.29 | 0.39 | -0.63 | 1.52 | 0.99 | 1.29 | 0.89 | 0.46 | 1.26 |
| Balance Sheet | |||||||||||
| Total Assets | 20.6M | 491M | 513M | 729M | 817M | 867M | 966M | 933M | 1.35B | 2.22B | 2.34B |
| Total Liabilities | 20.4M | 154M | 106M | 368M | 372M | 357M | 408M | 523M | 841M | 1.66B | 1.71B |
| Shareholders' Equity | 270K | 160M | 181M | 192M | 331M | 448M | 543M | 614M | 713M | 779M | 857M |
| Cash & Short-term Investments | 8.66M | 121M | 108M | 220M | 261M | 287M | 294M | 296M | 291M | 429M | 396M |
| Total Debt | 9.89M | 6.25M | 13.7M | 257M | 261M | 201M | 229M | 321M | 472M | 1.08B | 977M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -8.14M | 53.1M | 26.1M | 13.7M | 46.2M | 70.3M | 82.1M | 68.2M | 52.2M | 115M | 247M |
| Capital Expenditure | 298K | 2.08M | 1.17M | 1.04M | 1.16M | 19.2M | 22.9M | 28.5M | 8.03M | 10.1M | 20.9M |
| Free Cash Flow | -8.44M | 51.0M | 24.9M | 12.6M | 45.0M | 51.1M | 59.2M | 39.7M | 44.2M | 104M | 226M |
| Ratios | |||||||||||
| ROE | -3,317.6% | 16.1% | 6.0% | 7.4% | -7.2% | 15.4% | 8.3% | 9.9% | 6.1% | 2.9% | 7.3% |
| ROA | -43.4% | 5.3% | 2.1% | 1.9% | -2.9% | 7.9% | 4.7% | 6.5% | 3.2% | 1.0% | 2.7% |
| Net Profit Margin | -15.6% | 7.2% | 2.1% | 2.5% | -6.4% | 8.9% | 3.9% | 4.4% | 2.1% | 0.7% | 1.6% |
| Debt to Equity | 36.59x | 0.04x | 0.08x | 1.34x | 0.79x | 0.45x | 0.42x | 0.52x | 0.66x | 1.38x | 1.14x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Astrana Health Inc dividends
- Dividend yield
- 0.50%
- Forward dividend
- -
- Payout ratio
- 35.1%
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 7.89M | 0.16 | 35.1% |
| 2024 | USD 4.04M | 0.08 | 9.4% |
| 2023 | USD 62.1M | 1.32 | 102.2% |
| 2022 | USD 14.0M | 0.31 | 31.1% |
| 2021 | USD 31.1M | 0.68 | 45.1% |
| 2020 | USD 51.3M | 1.37 | - |
| 2019 | USD 61.7M | 1.70 | 437.2% |
| 2018 | USD 17.8M | 0.47 | 163.9% |
| 2017 | USD 10.4M | 0.36 | 40.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:10 on Apr 27, 2015.
Who owns Astrana Health Inc
- Insiders 22.75%
- Institutions 68.75%
- Public & others 8.50%
- Shares outstanding 49.7M
- Free float 45.7M
Top funds holding ASTH.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 2.52M | 5.12% | -0.21% | Oct 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.42M | 2.87% | 0.00% | Sep 2026 |
| iShares Russell 2000 ETF | 1.16M | 2.34% | 0.00% | Oct 2026 |
| Vanguard Small Cap Index | 1.00M | 2.04% | -1.98% | Sep 2026 |
| Vanguard MStar Small Cap Growth Indx Inv | 559K | 1.13% | -4.81% | Sep 2026 |
| Fidelity Small Cap Index | 500K | 1.01% | +0.15% | Aug 2026 |
| Diamond Hill Small Cap Inv | 495K | 1.00% | +0.81% | Sep 2026 |
| iShares Russell 2000 Growth ETF | 428K | 0.87% | -0.38% | Oct 2026 |
| Fidelity Select Health Care Svcs Port | 388K | 0.79% | -3.72% | Sep 2026 |
| State Street SPDR Port S&P 600 Sm CpETF | 383K | 0.78% | -0.05% | Oct 2026 |
| iShares S&P Small-Cap 600 Value ETF | 347K | 0.70% | 0.00% | Oct 2026 |
| Fidelity Small Cap Growth | 319K | 0.65% | 0.00% | Aug 2026 |
| Vanguard Tax-Managed Small Cap Adm | 304K | 0.62% | 0.00% | Sep 2026 |
| DFA U.S. Small Cap Value I | 268K | 0.54% | +85.08% | Sep 2026 |
| Vanguard Russell 2000 ETF | 265K | 0.54% | +1.17% | Sep 2026 |
| First Trust Small Cap Gr AlphaDEX® ETF | 241K | 0.49% | +0.43% | Oct 2026 |
| State Street® SPDR® S&P 600™ Sm CpValETF | 225K | 0.46% | 0.00% | Oct 2026 |
| Schwab US Small-Cap ETF™ | 223K | 0.45% | +0.23% | Oct 2026 |
| Royce Small-Cap Opportunity Invmt | 215K | 0.44% | -3.56% | Sep 2026 |
| DFA U.S. Small Cap I | 199K | 0.40% | +0.51% | Sep 2026 |
Top institutions holding ASTH.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 6.90M | 13.99% | +11.95% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 2.61M | 5.28% | +14.45% | Jun 2026 |
| Vanguard Capital Management, LLC | 1.95M | 3.95% | +13.81% | Jun 2026 |
| State Street Corp | 1.74M | 3.53% | +5.36% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 1.64M | 3.33% | +11.78% | Sep 2026 |
| 325 Capital LLC | 1.61M | 3.27% | -12.25% | Jun 2026 |
| Wellington Management Company LLP | 1.29M | 2.62% | -3.67% | Jun 2026 |
| Geode Capital Management, LLC | 1.17M | 2.37% | +12.51% | Jun 2026 |
| Bank of America Corp | 852K | 1.73% | +48.27% | Jun 2026 |
| FMR Inc | 686K | 1.39% | +64.84% | Jun 2026 |
| Wells Fargo & Co | 665K | 1.35% | +545.58% | Jun 2026 |
| Charles Schwab Investment Management Inc | 653K | 1.32% | +1.32% | Jun 2026 |
| Ameriprise Financial Inc | 512K | 1.04% | -7.16% | Jun 2026 |
| Northern Trust Corp | 505K | 1.02% | +15.26% | Jun 2026 |
| Diamond Hill Capital Management, LLC | 476K | 0.97% | -12.52% | Jun 2026 |
| Royce & Associates, LP | 472K | 0.96% | +19.02% | Jun 2026 |
| Steel Peak Wealth Management LLC | 465K | 0.94% | -16.97% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 434K | 0.88% | +27.95% | Jun 2026 |
| Amvescap Plc. | 382K | 0.77% | +8.75% | Jun 2026 |
| Vanguard Fiduciary Trust Co | 307K | 0.62% | +4.78% | Jun 2026 |
Astrana Health Inc company profile
- Company name
- Astrana Health Inc
- Ticker
- ASTH.US
- Exchange
- USA Stocks
- Listed since
- Jan 13, 2000
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 3,000
- Fiscal year end
- December
- Address
- 1668 S. Garfield Avenue, Alhambra, CA, United States, 91801
- Phone
- 626 282 0288
- Website
- astranahealth.com
About Astrana Health Inc
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.
Astrana Health Inc management
10- Dr. Kenneth T. Sim F.A.C.S., M.D.Co-Founder & Executive Chairman · born 1954
- Mr. Brandon K. Sim M.S.President & CEO · born 1994
- Dr. Thomas S. Lam M.D., M.P.H.Co-Founder & Vice Chairman · born 1949
- Mr. Chandan Basho M.B.A.CFO, COO & Corporate Secretary · born 1983
- Mr. John Vong CPA, CGMA, M.B.A.Senior VP of Accounting & Principal Accounting Officer · born 1973
- Ms. Rita Pew M.B.A.Chief People Officer
- Dr. WaiChow Young M.D., M.P.H.Senior Vice President of Health Affairs · born 1948
- Dr. Jeremy R. Jackson M.D.Chief Quality Officer
- Ms. Jaime Melkonoff M.B.A.President of AstranaCare - Texas
- Mr. Edgar GarroboVP of Information Security & CISO